← Leaderboards
Barry P Sleckman
University Of Alabama At Birmingham
$19,849,738
Attributed
$21,548,917
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.2M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$67,148,904 · 12
By mechanism
P30$50,383,440 · 6
R01$15,931,744 · 4
R21$833,720 · 2
Top collaborators
- Craig H. Bassing5 shared
- Larry A. Sklar4 shared
- Eugene M. Oltz2 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Zhixin Zhang$4,197,162
- Harry William Schroeder$20,383,747
- Eben L Rosenthal$10,844,750
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsPathway InteractionsPreventProgramsComprehensive Cancer CenterSignal TransductionProteinsCellsResponseMediatingDna DamageDna Double Strand BreakRepairedDouble Strand Break RepairScreeningLeadReceptor GeneGenomic InstabilityMissionB-LymphocytesIncidenceMemberAntigen ReceptorsStrategic Planning
Grant awards (92)
Comprehensive Cancer Center Support Grant$5,495,514
P30 · FY2025 · CA · contact PI
Leadership, Planning, and Evaluation$457,959
P30 · FY2025 · CA · contact PI
Comprehensive Cancer Center Support Grant$250,000
P30 · FY2025 · CA · contact PI
Comprehensive Cancer Center Support Grant$245,191
P30 · FY2025 · CA · contact PI
Comprehensive Cancer Center Support Grant$185,625
P30 · FY2025 · CA · contact PI
Comprehensive Cancer Center Support Grant$69,669
P30 · FY2025 · CA · contact PI
Comprehensive Cancer Center Support Grant$5,495,514
P30 · FY2024 · CA · contact PI
Leadership, Planning, and Evaluation$493,755
P30 · FY2024 · CA · contact PI
Comprehensive Cancer Center Support Grant$215,332
P30 · FY2024 · CA · contact PI
Comprehensive Cancer Center Support Grant$211,731
P30 · FY2024 · CA · contact PI
Comprehensive Cancer Center Support Grant$199,795
P30 · FY2024 · CA · contact PI
Comprehensive Cancer Center Support Grant$185,625
P30 · FY2024 · CA · contact PI
Comprehensive Cancer Center Support Grant$5,495,514
P30 · FY2023 · CA · contact PI
Leadership, Planning, and Evaluation$493,758
P30 · FY2023 · CA · contact PI
ATM Function During V(D)J Recombination$371,250
R01 · FY2023 · AI · contact PI
Comprehensive Cancer Center Support Grant$211,912
P30 · FY2023 · CA · contact PI
Comprehensive Cancer Center Support Grant$199,989
P30 · FY2023 · CA · contact PI
Comprehensive Cancer Center Support Grant$5,495,514
P30 · FY2022 · CA · contact PI
Leadership, Planning, and Evaluation$493,758
P30 · FY2022 · CA · contact PI
ATM Function During V(D)J Recombination$371,250
R01 · FY2022 · AI · contact PI
Project-005$75,000
P30 · FY2022 · CA · contact PI
Comprehensive Cancer Center Support Grant$75,000
P30 · FY2022 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$5,155,276
P30 · FY2021 · CA · contact PI
Administrative Core$1,167,889
P30 · FY2021 · CA · contact PI
Developmental Funds$594,000
P30 · FY2021 · CA · contact PI
ATM Function During V(D)J Recombination$371,250
R01 · FY2021 · AI · contact PI
The V(D)J Recombination Reaction and ITS impact on Lymphocyte Development$371,250
R01 · FY2021 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$52,500
R01 · FY2021 · AI · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$5,103,202
P30 · FY2020 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$742,500
P30 · FY2020 · CA · contact PI
Administrative Core$584,560
P30 · FY2020 · CA · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$423,750
R01 · FY2020 · AI · contact PI
Developmental Funds$422,774
P30 · FY2020 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$390,999
P30 · FY2020 · CA · contact PI
COVID-19 and Its Implications for Cancer Prevention and Control: A Collaborative Effort Across Cancer Centers$371,250
P30 · FY2020 · CA · contact PI
The V(D)J Recombination Reaction and ITS impact on Lymphocyte Development$371,250
R01 · FY2020 · AI · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$150,000
P30 · FY2020 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$150,000
P30 · FY2020 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$100,000
P30 · FY2020 · CA · contact PI
The V(D)J recombination reaction and its impact on lymphocyte development$52,500
R01 · FY2020 · AI · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$52,039
P30 · FY2020 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$5,103,202
P30 · FY2019 · CA · contact PI
Comprehensive Cancer Center Core Support Grant$3,827,965
P30 · FY2019 · CA · contact PI
The V(D)J recombination reaction and its impact on lymphocyte development$423,750
R01 · FY2019 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$423,750
R01 · FY2019 · AI · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$200,000
P30 · FY2019 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$125,000
P30 · FY2019 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$38,074
P30 · FY2019 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$32,500
P30 · FY2019 · CA · contact PI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$26,055
P30 · FY2019 · CA · contact PI
The V(D)J recombination reaction and its impact on lymphocyte development$423,750
R01 · FY2018 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$419,353
R01 · FY2018 · AI · contact PI
The V(D)J recombination reaction and its impact on lymphocyte development$423,750
R01 · FY2017 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$419,353
R01 · FY2017 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$419,353
R01 · FY2016 · AI · contact PI
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT$404,727
R01 · FY2016 · CA · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$16,611
R01 · FY2016 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$380,000
R01 · FY2015 · AI · contact PI
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT$361,217
R01 · FY2015 · CA · contact PI
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT$145,600
R01 · FY2015 · CA · contact PI
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT$462,633
R01 · FY2014 · CA · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$380,000
R01 · FY2014 · AI · contact PI
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENT$376,200
R01 · FY2014 · AI · contact PI
INHIBITORS OF COMPENSATORY NHEJ PATHWAYS$225,720
R21 · FY2014 · ES · contact PI
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENT$353,628
R01 · FY2013 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$350,092
R01 · FY2013 · AI · contact PI
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS$299,407
R01 · FY2013 · CA · contact PI
INHIBITORS OF COMPENSATORY NHEJ PATHWAYS$190,000
R21 · FY2013 · ES · contact PI
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENT$376,200
R01 · FY2012 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$372,438
R01 · FY2012 · AI · contact PI
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS$318,518
R01 · FY2012 · CA · contact PI
LOCALIZED REVISION OF EPIGENETIC LANDSCAPES INDUCED BY DNA DOUBLE-STRAND BREAKS$190,000
R21 · FY2012 · ES · contact PI
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENT$376,200
R01 · FY2011 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$372,438
R01 · FY2011 · AI · contact PI
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS$318,518
R01 · FY2011 · CA · contact PI
LOCALIZED REVISION OF EPIGENETIC LANDSCAPES INDUCED BY DNA DOUBLE-STRAND BREAKS$228,000
R21 · FY2011 · ES · contact PI
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENT$380,000
R01 · FY2010 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$376,200
R01 · FY2010 · AI · contact PI
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS$328,369
R01 · FY2010 · CA · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$380,000
R01 · FY2009 · AI · contact PI
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS$341,369
R01 · FY2009 · CA · contact PI
Regulation of TCRBeta Chain Gene Rearrangement$320,211
R01 · FY2009 · AI · contact PI
ATM FUNCTION DURING V(D)J RECOMBINATION$17,439
R01 · FY2009 · AI · contact PI
Regulation of TCRBeta Chain Gene Rearrangement$320,211
R01 · FY2008 · AI · contact PI
Regulation of TCRBeta Chain Gene Rearrangement$326,412
R01 · FY2007 · AI · contact PI
Regulation of TCRBeta Chain Gene Rearrangement$336,161
R01 · FY2006 · AI · contact PI
Regulation of TCRBeta Chain Gene Rearrangement$344,250
R01 · FY2005 · AI
REGULATION OF TCRB CHAIN GENE REARRANGEMENT$308,000
R01 · FY2004 · AI
REGULATION OF TCRB CHAIN GENE REARRANGEMENT$308,000
R01 · FY2003 · AI
REGULATION OF TCRB CHAIN GENE REARRANGEMENT$277,200
R01 · FY2002 · AI
REGULATION OF TCRB CHAIN GENE REARRANGEMENT$308,000
R01 · FY2001 · AI
REGULATION OF TCRB CHAIN GENE REARRANGEMENT$257,436
R01 · FY2000 · AI